Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377796
    value: Clinical subtype
  Genes:
  - Gene:
      DisorderGeneAssociationType: Disease-causing somatic mutation(s) in
      ExternalReferences:
      - Reference: TET2
        Source: ClinVar
      - Reference: '25941'
        Source: HGNC
      - Reference: '612839'
        Source: OMIM
      Name: tet methylcytosine dioxygenase 2
      Symbol: TET2
  Label: Myelodysplastic neoplasm with increased blasts type 2
  ORPHAcode: '100020'
  ORPHApacketId: '100020'
  PURL: http://www.orpha.net/ORDO/Orphanet_100020
  Parents:
  - Parent:
    - Label: Myelodysplastic neoplasm with increased blasts
      ORPHAcode: '86839'
  Prevalences:
    Prevalence:
    - PrevalenceClass: Unknown
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET
      ValMoy: '0.0'
  Synonyms:
  - Synonym: RAEB-2
  - Synonym: MDS-IB2
  - Synonym: Refractory anemia with excess blasts type 2
  TextSection:
    Contents: 'A very severe type of RAEB characterized by cytopenias and the following
      hematological parameters: uni- or multilineage dysplasia 10% to 19% blasts in
      bone marrow or 5% to 19% in peripheral blood variable presence of Auer rods
      (abnormal needle-shaped or round inclusions in the cytoplasm of myeloblasts
      and promyelocytes). Median survival has been reported to be 18 months.'
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2025
  creationDate: '2025-06-26 11:48:15'
  version: 1.3.42 / 4.1.8 [2025-03-03]
